Serum insulin-like growth factor-1 concentrations are reduced in severely obese women and raise after weight loss induced by laparoscopic adjustable gastric banding

Obesity Surgery

Volumn 22, Issue 8, 2012, Pages 1276-1280

  Galli, Giulia ^a   Pinchera, Aldo ^a   Piaggi, Paolo ^b   Fierabracci, Paolo ^a   Giannetti, Monica ^a   Querci, Giorgia ^a   Scartabelli, Giovanni ^a   Manetti, Luca ^a   Ceccarini, Giovanni ^a   Martinelli, Silvia ^a   Di Salvo, Claudio ^a   Anselmino, Marco ^a   Bogazzi, Fausto ^a,c   Landi, Alberto ^b   Vitti, Paolo ^a   Maffei, Margherita ^a   Santini, Ferruccio ^a  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c National Council of Research   (Italy)

Author keywords

Insulin like growth factor 1; Laparoscopic adjustable gastric banding; Obesity

Indexed keywords

SOMATOMEDIN C;

ABDOMINAL FAT; ABDOMINAL RADIOGRAPHY; ADULT; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GASTRIC BANDING; HUMAN; LIVER WEIGHT; LONG TERM CARE; MAJOR CLINICAL STUDY; OBESITY; OUTCOME ASSESSMENT; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WEIGHT REDUCTION;

ADULT; BODY MASS INDEX; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GASTROPLASTY; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTRA-ABDOMINAL FAT; LIVER; OBESITY, MORBID; PREMENOPAUSE; PROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 84864884706     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-012-0669-1     Document Type: Article

References (28)

1. Veldhuis JD, Iranmanesh A, Ho KK, et al. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab. 1991;72:51-9.
2. Maccario M, Valetto MR, Savio P, et al. Maximal secretory capacity of somatotrope cells in obesity: Comparison with GH deficiency. Int J Obes Relat Metab Disord. 1997;21:27-32.
3. Savastano S, Di Somma C, Belfiore A, et al. Growth hormone status in morbidly obese subjects and correlation with body composition. J Endocrinol Invest. 2006;29:536-43.
4. Makimura H, Stanley T, Mun D, et al. The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men. J Clin Endocrinol Metab. 2008;93:4254-60.
5. Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res. 2003;13:113-70.
6. Brick DJ, Gerweck AV, Meenaghan E, et al. Determinants of IGF1 and GH across the weight spectrum: From anorexia nervosa to obesity. Eur J Endocrinol. 2010;163:185-91.
7. Kreitschmann-Andermahr I, Suarez P, Jennings R, et al. GH/IGF-I regulation in obesity-mechanisms and practical consequences in children and adults. Horm Res Paediatr. 2010;73:153-60.
8. Rasmussen MH. Obesity, growth hormone and weight loss. Mol Cell Endocrinol. 2010;316:147-53.
9. Rasmussen MH, Hvidberg A, Juul A, et al. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab. 1995;80:1407-15.
10. Belobrajdic DP, Frystyk J, Jeyaratnaganthan N, et al. Moderate energy restriction-induced weight loss affects circulating IGF levels independent of dietary composition. Eur J Endocrinol. 2010;162:1075-82.
11. Rasmussen MH, Juul A, Kjems LL, et al. Lack of stimulation of 24-hour growth hormone release by hypocaloric diet in obesity. J Clin Endocrinol Metab. 1995;80:796-801.
12. Pories WJ. Bariatric surgery: Risks and rewards. J Clin Endocrinol Metab. 2008;93:S89-96.
13. Pontiroli AE, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery. a systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg. 2011;253:484-7.
14. Dixon JB, Laurie CP, Anderson ML, et al. Motivation, readiness to change, and weight loss following adjustable gastric band surgery. Obes (Silver Spring). 2009;17:698-705.
15. Piaggi P, Lippi C, Fierabracci P, et al. Artificial neural networks in the outcome prediction of adjustable gastric banding in obese women. PLoS One. 2010;5:e13624.
16. Di Somma C, Angrisani L, Rota F, et al. GH and IGF-I deficiency are associated with reduced loss of fat mass after laparoscopicadjustable silicone gastric banding. Clin Endocrinol (Oxf). 2008;69:393-9.
17. Savastano S, Di Somma C, Angrisani L, et al. Growth hormone treatment prevents loss of lean mass after bariatric surgery in morbidly obese patients: Results of a pilot, open, prospective, randomized, controlled study. J Clin Endocrinol Metab. 2009;94:817-26.
18. Savastano S, Angrisani L, Di Somma C, et al. Relationship between growth hormone/insulin-like growth factor-1 axis integrity and voluntary weight loss after gastric banding surgery for severe obesity. Obes Surg. 2010;20:211-20.
19. Ho KK. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: A statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol. 2007;157:695-700.
20. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-9.
21. Santini F, Giannetti M, Mazzeo S, et al. Ultrasonographic evaluation of liver volume and the metabolic syndrome in obese women. J Endocrinol Invest. 2007;30:104-10.
22. Giannetti M, Piaggi P, Ceccarini G, et al. Hepatic left lobe volume is a sensitive index of metabolic improvement in obese women after gastric banding. Int J Obes (Lond). 2011;36:336-41.
23. Corneli G, Di Somma C, Baldelli R, et al. The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. Eur J Endocrinol. 2005;153:257-64.
24. Molitch ME, Clemmons DR, Malozowski S, et al. Evaluation and treatment of adult growth hormone deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2006;91:1621-34.
25. Tzanela M, Zianni D, Bilariki K, et al. The effect of body mass index on the diagnosis of GH deficiency in patients at risk due to a pituitary insult. Eur J Endocrinol. 2010;162:29-35.
26. Fierabracci P, Pinchera A, Martinelli S, et al. Prevalence of endocrine diseases in morbidly obese patients scheduled for bariatric surgery: beyond diabetes. Obes Surg. 2011;21:54-60.
27. Bogazzi F, Manetti L, Lombardi M, et al. Impact of different cutoff limits of peak GH after GHRH-arginine stimulatory test, single IGF1 measurement, or their combination in identifying adult patients with GH deficiency. Eur J Endocrinol. 2011;164:685-93.
28. Vandeva S, Rixhon M, Tichomirowa MA, et al. Learning from recombinant GH treatment in obesity. Obes Metab. 2009;5:156-66.